Relative bioavailability and pharmacokinetic (PK) performance of a ralinepag extended-release (XR) tablet oral formulation and the effect of food and gender in healthy human subjects
Event: ESC Congress 2018
Topic: Pulmonary Hypertension
Session: Pulmonary hypertension: progress in management, impact on outcomes
Comparative receptor pharmacology, pre-clinical efficacy and pharmacokinetics of a novel, next-generation prostacyclin receptor agonist, ralinepag (APD811), in humans and rats
Event: ESC Congress 2017
Topic: Chronic pulmonary hypertension
Session: Progress in the management of pulmonary hypertension
